PD-L1 expression on immune cells, in particular on DCs and macrophages, has been acknowledged to extensively contribute to the evasion of the anti-tumor immune response35 and predicts clinical responses better than PD-L1 expression on tumor cells.20 Here, CD274 is linked to neoplasm.